Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Lacosamide vs Carbamazepine-CR in Epilepsy Monotherapy
NCT01465997Phase 3Completed
- Sponsor
- UCB
- Start
- May 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started May 2012; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01465997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465997.